<?xml version="1.0" encoding="UTF-8"?><!DOCTYPE article  PUBLIC "-//NLM//DTD Journal Publishing DTD v3.0 20080202//EN" "http://dtd.nlm.nih.gov/publishing/3.0/journalpublishing3.dtd"><article xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" dtd-version="3.0" xml:lang="en" article-type="research article"><front><journal-meta><journal-id journal-id-type="publisher-id">ACM</journal-id><journal-title-group><journal-title>Advances in Clinical Medicine</journal-title></journal-title-group><issn pub-type="epub">2161-8712</issn><publisher><publisher-name>Scientific Research Publishing</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="doi">10.12677/ACM.2018.89137</article-id><article-id pub-id-type="publisher-id">ACM-27457</article-id><article-categories><subj-group subj-group-type="heading"><subject>ACM20180900000_61536885.pdf</subject></subj-group><subj-group subj-group-type="Discipline-v2"><subject>医药卫生</subject></subj-group></article-categories><title-group><article-title>
 
 
  人乳头瘤病毒感染与肺癌关系的研究进展
  Advances in the Relationship between Human Papillomavirus Infection and Lung Cancer
 
</article-title></title-group><contrib-group><contrib contrib-type="author" xlink:type="simple"><name name-style="western"><surname>戴</surname><given-names>晓玥</given-names></name><xref ref-type="aff" rid="aff2"><sup>2</sup></xref><xref ref-type="aff" rid="aff1"><sup>1</sup></xref></contrib><contrib contrib-type="author" xlink:type="simple"><name name-style="western"><surname>吴</surname><given-names>亮</given-names></name><xref ref-type="aff" rid="aff2"><sup>2</sup></xref><xref ref-type="aff" rid="aff1"><sup>1</sup></xref></contrib></contrib-group><aff id="aff2"><addr-line>江苏大学医学院，江苏 镇江</addr-line></aff><aff id="aff1"><addr-line>null</addr-line></aff><pub-date pub-type="epub"><day>02</day><month>11</month><year>2018</year></pub-date><volume>08</volume><issue>09</issue><fpage>819</fpage><lpage>824</lpage><permissions><copyright-statement>&#169; Copyright  2014 by authors and Scientific Research Publishing Inc. </copyright-statement><copyright-year>2014</copyright-year><license><license-p>This work is licensed under the Creative Commons Attribution International License (CC BY). http://creativecommons.org/licenses/by/4.0/</license-p></license></permissions><abstract><p>
 
 
  
    肺癌是严重危害人类健康的恶性肿瘤，近30年来发病率和死亡率呈直线上升趋势，现已居全球各类恶性肿瘤的首位。传统观念认为吸烟是导致肺癌的主要原因，但上述观点并不能解释15%以上终身不吸烟女性肺癌患者发病原因，并且目前认为至少有50%的非吸烟女性肺癌患者发病原因尚不明确。近年来，随着大量针对亚洲肺癌女性患者研究的开展，人乳头瘤病毒感染与肺癌的相关性逐渐引起研究者重视。本文对近年来HPV和肺癌关系的研究进展作简要综述。
    Lung cancer is a malignant tumor that seriously endangers human healthy. In the past 30 years, the morbidity and mortality of it have been rising in a straight line. It was considered that smoking is the main cause of lung cancer before, but the above opinion cannot explain the reason of lung cancer in more than 15% of non-smoking female patients. At present, it is still unclear that the cause of about half of non-smoking female patients who have lung cancer. In recent years, with mas-sive of studies on Asian women with lung cancer, the correlation between human papillomavirus in-fection and lung cancer has attracted more and more attention from researchers. This paper briefly reviews the research progress of the relationship between HPV and lung cancer in recent years. 
  
 
</p></abstract><kwd-group><kwd>肺癌，HPV，毒力因子，致病机制, Lung Cancer</kwd><kwd> HPV</kwd><kwd> Virulence Factors</kwd><kwd> Pathogenic Mechanism</kwd></kwd-group></article-meta></front><body><sec id="s1"><title>人乳头瘤病毒感染与肺癌关系的研究进展<sup> </sup></title><p>戴晓玥，吴亮<sup>*</sup></p><p>江苏大学医学院，江苏 镇江</p><p><img src="//html.hanspub.org/file/7-1570719x1_hanspub.png" /></p><p>收稿日期：2018年10月17日；录用日期：2018年11月1日；发布日期：2018年11月8日</p><disp-formula id="hanspub.27457-formula94"><graphic xlink:href="//html.hanspub.org/file/7-1570719x5_hanspub.png"  xlink:type="simple"/></disp-formula></sec><sec id="s2"><title>摘 要</title><p>肺癌是严重危害人类健康的恶性肿瘤，近30年来发病率和死亡率呈直线上升趋势，现已居全球各类恶性肿瘤的首位。传统观念认为吸烟是导致肺癌的主要原因，但上述观点并不能解释15%以上终身不吸烟女性肺癌患者发病原因，并且目前认为至少有50%的非吸烟女性肺癌患者发病原因尚不明确。近年来，随着大量针对亚洲肺癌女性患者研究的开展，人乳头瘤病毒感染与肺癌的相关性逐渐引起研究者重视。本文对近年来HPV和肺癌关系的研究进展作简要综述。</p><p>关键词 :肺癌，HPV，毒力因子，致病机制</p><disp-formula id="hanspub.27457-formula95"><graphic xlink:href="//html.hanspub.org/file/7-1570719x7_hanspub.png"  xlink:type="simple"/></disp-formula><p>Copyright &#169; 2018 by authors and Hans Publishers Inc.</p><p>This work is licensed under the Creative Commons Attribution International License (CC BY).</p><p>http://creativecommons.org/licenses/by/4.0/</p><p><img src="//html.hanspub.org/file/7-1570719x8_hanspub.png" /> <img src="//html.hanspub.org/file/7-1570719x9_hanspub.png" /></p></sec><sec id="s3"><title>1. 引言</title><p>我国是世界肺癌发病率第一的大国。通常认为肺癌的发生与吸烟、呼吸系统疾病、环境污染、职业致癌因素和室内氡污染等有关 [<xref ref-type="bibr" rid="hanspub.27457-ref1">1</xref>] [<xref ref-type="bibr" rid="hanspub.27457-ref2">2</xref>] [<xref ref-type="bibr" rid="hanspub.27457-ref3">3</xref>] [<xref ref-type="bibr" rid="hanspub.27457-ref4">4</xref>]，其中吸烟是公认为引起肺癌的最重要因素。但近年来的流行病学研究表明，非吸烟者尤其是女性肺癌患者的比例增高明显，全球至少有15%的肺癌患者为终身非吸烟者，而且这现象在东亚女性中的比例可能更高。通过PCR法检测此类患者血液中HPV-DNA发现，此类患者HPV感染率明显高于正常人，该结果提示HPV感染可能是肺癌发生一个重要因素 [<xref ref-type="bibr" rid="hanspub.27457-ref5">5</xref>]。HPV虽然已被明确在宫颈癌发生发展中的作用，但在肺癌中的作用仍有争议。本文将综述HPV分子致病机制的研究进展。</p></sec><sec id="s4"><title>2. HPV感染与肺癌相关性研究</title><sec id="s4_1"><title>2.1. 流行病学现状</title><p>人乳头状瘤病毒(HPV)与宫颈癌和其他癌症如肛门-生殖器癌和口咽癌 [<xref ref-type="bibr" rid="hanspub.27457-ref6">6</xref>] [<xref ref-type="bibr" rid="hanspub.27457-ref7">7</xref>] 有着不可忽视的联系，同时，虽然吸烟是公认的诱导肺癌最密切的危险因素，但非吸烟者肺癌人群的病因引起了重视。自从Syrjanen在1979年 [<xref ref-type="bibr" rid="hanspub.27457-ref8">8</xref>] 首次将HPV作为肺癌肿瘤发生的潜在危险因素，HPV感染与肺癌的发生发展的相关性引起了重视，但随后也有研究对这一结论提出争议 [<xref ref-type="bibr" rid="hanspub.27457-ref9">9</xref>]。HPV感染的分布模式似乎是存在地区差异，亚洲地区的研究结果显示HPV阳性率普遍较高，而在西欧和美国感染率较低 [<xref ref-type="bibr" rid="hanspub.27457-ref10">10</xref>]。这可能由于地区差异，存在不同的生活习惯以及其他潜在的文化差异，这些都可能会影响HPV流行病学结果。此外，研究人员在检测方法上缺乏一定的共识以及方法上可能存在缺陷，都会造成研究中的巨大差异，特别是在相同地域内也出现关于HPV流行病学结果的不同 [<xref ref-type="bibr" rid="hanspub.27457-ref9">9</xref>]。</p><p>肺癌可分为两大类，包括非小细胞肺癌(NSCLC)，约占70%~80%；小细胞肺癌(SCLC)，约占20%。非小细胞肺癌可分为鳞状细胞癌、腺癌和大细胞癌，其中鳞状细胞癌和小细胞癌与吸烟密切相关，而腺癌在非吸烟者中较为常见。大量实验研究 [<xref ref-type="bibr" rid="hanspub.27457-ref11">11</xref>] - [<xref ref-type="bibr" rid="hanspub.27457-ref16">16</xref>] 发现非吸烟肺癌患者与吸烟肺癌患者肿瘤发生的分子机制存在显著差异，某些感染性疾病(如HPV)可能非吸烟者肺癌发生的重要因素。</p></sec><sec id="s4_2"><title>2.2. HPV分型</title><p>HPV属于乳多空病毒科，乳头瘤空泡病毒A属，能引起人体皮肤和粘膜鳞状上皮增殖。其基因组包括了6个早期基因(E1、E2、E4、E5、E6、E7)和2个晚期基因(L1、L2)及非编码区调控区 [<xref ref-type="bibr" rid="hanspub.27457-ref17">17</xref>]。早期基因参与病毒DNA的复制、转录、翻译和转化及其调控等功能，晚期基因分别编码主要外壳蛋白和次要外壳蛋白，非编码区包含复制起点和HPV表达所需的调控元件等。根据致病性可将HPV分为高危型、中危型和低危型 [<xref ref-type="bibr" rid="hanspub.27457-ref18">18</xref>]。高危型HPV的E6和E7可诱导细胞向肿瘤细胞转化，被认为是主要的致癌蛋白，前者使抑癌基因p53蛋白降解，进而导致细胞周期失控，后者调节Rb蛋白的活性使细胞永生化。</p></sec><sec id="s4_3"><title>2.3. HPV与肺癌相关性</title><p>1970年，Syrjanen等 [<xref ref-type="bibr" rid="hanspub.27457-ref8">8</xref>] [<xref ref-type="bibr" rid="hanspub.27457-ref19">19</xref>] 最早报道了肺鳞癌周围的支气管上皮内有与生殖道湿疣相似的病变，并提出应重视肺部类似病变。通过其进一步研究发现30%的支气管鳞状上皮组织活检结果提示有类似HPV感染的形态学改变，进而提出HPV可引起肺鳞癌发生的假说。1987年Syrjanen等 [<xref ref-type="bibr" rid="hanspub.27457-ref20">20</xref>] 使用原位杂交法检测气管鳞癌患者组织中HPV16、HPV11、HPV6、HPV18和HPV30发现超过5%的支气管鳞癌患者组织可检出HPV-DNA，首次证实支气管鳞癌细胞中存在HPV的感染。</p><p>后续研究发现亚洲支气管鳞癌患者组织中HPV感染率最高，其次为欧洲和大洋洲，不同地区肺癌患者组织中HPV类型并不相同。尽管人们已经意识到HPV感染可能与肺癌的发生密切相关，但HPV与肺癌的关系仍未完全明晰。</p></sec><sec id="s4_4"><title>2.4. HPV感染肺部组织的潜在途径</title><p>呼吸道粘膜存在两种不同类型的上皮细胞，其咽部由柱状上皮细胞构成，喉和气管由鳞状上皮细胞构成。在某些外在因素的诱导下，鳞状上皮细胞向鳞状化生细胞的组织学转变是HPV诱发肿瘤的理想切入点 [<xref ref-type="bibr" rid="hanspub.27457-ref10">10</xref>]。<sup> </sup></p><p>肺组织中HPV感染途径有如下两种。第一种是HPV通过口腔扩散到肺中，一些研究结果提示口咽癌患者中特殊性行为是HPV感染的重要因素，所以口腔中的性行为可能是HPV进入肺组织的一种方式。另一种感染途径是血行，血中HPV来源于宫颈组织 [<xref ref-type="bibr" rid="hanspub.27457-ref21">21</xref>] [<xref ref-type="bibr" rid="hanspub.27457-ref22">22</xref>]，HPV-DNA易在非小细胞肺癌患者的血液中检出。此外研究表明白细胞细胞核具有转运HPV-DNA的能力。上述研究结果使我们相信血行通路可能是HPV在体内传播的主要原因之一，而白细胞可能是HPV感染与传播的主要载体。此外Carpagnano等 [<xref ref-type="bibr" rid="hanspub.27457-ref23">23</xref>] 还发现部分肺癌患者的呼吸冷凝物中存在HPV-DNA，这现象提示气流也是一种HPV可能的传播途径。</p></sec></sec><sec id="s5"><title>3. HPV诱导肺癌发生的分子机制</title><sec id="s5_1"><title>3.1. HPV-E6与抑癌基因p53的作用机制</title><p>E6癌蛋白的主要功能是使人的p53抑癌基因失活，此过程多通过E6AP复合体形成后与p53蛋白特异结合，致使p53降解和失活，从而导致细胞周期失控 [<xref ref-type="bibr" rid="hanspub.27457-ref24">24</xref>]。在肺癌细胞中，感染HPV的株系因p53与E6癌蛋白的相互作用，使得p53-DDX3途径改变，p21表达下降，导致肿瘤的异常生长 [<xref ref-type="bibr" rid="hanspub.27457-ref25">25</xref>]。</p></sec><sec id="s5_2"><title>3.2. E6与IL-10的作用机制</title><p>IL-10是巨噬细胞、T淋巴细胞和NK细胞所分泌的细胞因子，具有干扰免疫反应和建立潜在病毒感染的能力，在肿瘤的发生发展中有着重要作用 [<xref ref-type="bibr" rid="hanspub.27457-ref26">26</xref>]。在HPV感染细胞系中，E6通过CREB自身磷酸化和磷酸肌醇3激酶C-EBPβ(p13k)-AKT途径上调IL-10的表达，同时IL-10还上调凋亡蛋白抑制剂cIAP2释放，加速肿瘤的发生发展。</p></sec><sec id="s5_3"><title>3.3. E6与Bcl-2的作用机制</title><p>HPV16/18型的感染可导致线粒体Bcl-2基因表达水平上调，抑制细胞凋亡，导致肿瘤细胞异常生长。E6癌蛋白通过激活宿主细胞p13k/AKT途径，从而刺激Bcl-2的表达。在Bcl-2基因的3’UTR区域中存在对p53无反应的元件并同时抑制Bcl-2表达，因此人们普遍认为当E6抑制p53活性时，Bcl-2表达水平通常升高并导致细胞异常存活。</p></sec><sec id="s5_4"><title>3.4. E6与cIAP2的作用机制</title><p>cIAP2是抑制凋亡蛋白家族IAPs家族的一员，cIAP2的C-端为环状结构，具有泛素连接酶活性，N-端为3个BIR结构，可以通过不同方式阻止多种内/外源信号诱导细胞凋亡。cIAP2能抑制成熟细胞蛋白水解活性，并因此通过协同作用来防止细胞凋亡，确保细胞存活。研究表明E6癌蛋白通过EGFR/P13K/AKT途径和NF-kB的活化控制cIAP2表达，使HPV感染的肺癌细胞异常增殖。</p></sec><sec id="s5_5"><title>3.5. E6与表皮生长因子受体(EGFR)突变的相关性</title><p>在非吸烟的HPV阳性患者中，EGFR基因突变在肺癌中最常见 [<xref ref-type="bibr" rid="hanspub.27457-ref27">27</xref>]。E6癌蛋白诱导细胞的氧化应激，导致DNA损伤并引起MMR途径失活，使细胞丧失通过清除错误碱基配对以控制遗传稳定性能力，进而使8-OH-dG表达水平上调，使细胞癌变概率大为增加。</p></sec><sec id="s5_6"><title>3.6. E7对pRB的作用机制</title><p>在HPV感染的肺癌细胞中，E7癌蛋白与pRB结合导致E2F-RB-HDAC复合物的解离，同时染色质重塑和启动子超甲基化作用的发生使得HDAC和E2F释放，激活细胞增殖基因的转录以及灭活肿瘤抑制基因，如p16<sup>INK4</sup> [<xref ref-type="bibr" rid="hanspub.27457-ref28">28</xref>]。通常RB蛋白与转录因子E2F有高亲和力，两者结合后使组蛋白去乙酰化酶(HDAC)活化，进而抑制细胞增殖基因表达 [<xref ref-type="bibr" rid="hanspub.27457-ref29">29</xref>]。因此，通过CDKs途径使pRB磷酸化抑制HDAC和E2F耦联，使E2F相关基因得以表达，该过程可被四种INK蛋白抑制。所以INK4，pRB和CDK相应蛋白的活化是细胞G1期得以调控的重要组成部分 [<xref ref-type="bibr" rid="hanspub.27457-ref30">30</xref>]。<sup> </sup></p></sec><sec id="s5_7"><title>3.7. E7与芳香烃受体(AhR)的作用机制</title><p>芳香烃受体是配体激活的转录因子，通过配体结合2,3,7,8-四氯二苯并对二恶英(TCDD)调控基因表达 [<xref ref-type="bibr" rid="hanspub.27457-ref31">31</xref>]，从而通过AhR核转运蛋白使AhR进入核内进行异二聚化，形成三元复合物E2F-pRB-AhR和激活基因表达 [<xref ref-type="bibr" rid="hanspub.27457-ref32">32</xref>]，从而影响细胞生长。其中，RB蛋白充当AhR的转录共激活剂，pRB与AhR的结合使TCDD活化调控CYP1A1表达，使细胞周期停滞在G1阶段 [<xref ref-type="bibr" rid="hanspub.27457-ref33">33</xref>]。</p></sec><sec id="s5_8"><title>3.8. E6、E7在吸烟因素下诱导损伤机制</title><p>除了增强子和沉默子之外，HPV基因组LCR区域还含有启动子区域p97序列 [<xref ref-type="bibr" rid="hanspub.27457-ref34">34</xref>]，p97序列活性受HPV和细胞小分子的调节，这些小分子蛋白质与LCR区域中的特定位点相互作用，实现转录调控 [<xref ref-type="bibr" rid="hanspub.27457-ref35">35</xref>]。Pena等 [<xref ref-type="bibr" rid="hanspub.27457-ref36">36</xref>] 发现在肺部上皮细胞中，香烟烟雾冷凝物可激活HPVp97序列和E6、E7癌基因的表达，从而使肺部细胞的相关氧化性DNA损伤。</p></sec></sec><sec id="s6"><title>4. E6、E7基因突变位点</title><p>不同的HPV亚型感染的地域性和致病性有较大差异，这也与宫颈病变程度相关。16型E6/E7 DNA序列变异发生率较高，E6基因突变以T178G、T350G、T295G为主，E7基因突变以A647G、T846C为主。此外，研究发现其氨基酸序列有3个常见共突变，分别为E6-D32E(T96G)和E7-N29S(A86G)突变位点伴随存在、E6基因T295G-T350G共突变和T178G-A647G-T843C-T846C共突变。</p></sec><sec id="s7"><title>5. 结论</title><p>肺癌是一种多途径、多因素疾病，多项研究表明非吸烟者肺癌组织中有HPV-DNA的存在，但这是否是肺癌重要致病因素尚未确定，尚缺乏更大范围和更大标本量的流行病学调查研究结果。并且不同的国家或种族HPV感染率及类型存在显著差异，完善不同国家或种族HPV感染类型别的分布以及国家或种族特异性类型HPV致癌能力对于肺癌的预防具有重要临床意义。目前HPV感染诱发肺癌机制仍缺乏较细致研究，进一步开展HPV各种毒力蛋白，包括E6和E7蛋白等对细胞生物学功能的调控，加强临床肺癌病例中HPV病毒E6和E7等毒力蛋白基因突变情况与患者肺癌严重程度等数据收集与研究工作，将有助于人们深入了解HPV致癌机制，并可以为肺癌的预防和治疗提供更加有效的途径。</p></sec><sec id="s8"><title>文章引用</title><p>戴晓玥,吴 亮. 人乳头瘤病毒感染与肺癌关系的研究进展 Advances in the Relationship between Human Papillomavirus Infection and Lung Cancer[J]. 临床医学进展, 2018, 08(09): 819-824. https://doi.org/10.12677/ACM.2018.89137</p></sec><sec id="s9"><title>参考文献</title></sec></body><back><ref-list><title>References</title><ref id="hanspub.27457-ref1"><label>1</label><mixed-citation publication-type="other" xlink:type="simple">Sapkota, A., Gajalakshmi, V., Jetly, D.H., et al. (2008) Indoor Air Pollution from Solid Fuels and Risk of Hypopha-ryngeal/Laryngeal and Lung Cancers: A Multicentric Case-Control Study from India. International Journal of Epide-miology, 37, 321-328. https://doi.org/10.1093/ije/dym261</mixed-citation></ref><ref id="hanspub.27457-ref2"><label>2</label><mixed-citation publication-type="other" xlink:type="simple">Henschke, C.I. and Miettinen, O.S. (2004) Women’s Susceptibility to Tobacco Carcinogens. Lung Cancer, 43, 1-5.  
https://doi.org/10.1016/j.lungcan.2003.08.024</mixed-citation></ref><ref id="hanspub.27457-ref3"><label>3</label><mixed-citation publication-type="other" xlink:type="simple">Boffetta, P., Tubiana, M., Hill, C., et al. (2009) The Causes of Cancer in France. Annals of Oncology, 20, 550-555.  
https://doi.org/10.1093/annonc/mdn597</mixed-citation></ref><ref id="hanspub.27457-ref4"><label>4</label><mixed-citation publication-type="other" xlink:type="simple">Samet, J.M., Avila-Tang, E., Boffetta, P., et al. (2009) Lung Cancer in Never Smokers: Clinical Epidemiology and Environmental Risk Factors. Clinical Cancer Research, 15, 5626-5645. https://doi.org/10.1158/1078-0432.CCR-09-0376</mixed-citation></ref><ref id="hanspub.27457-ref5"><label>5</label><mixed-citation publication-type="other" xlink:type="simple">Lam, W.K. (2005) Lung Cancer in Asian Women: The Environment and Genes. Respirology, 10, 408-417.  
https://doi.org/10.1111/j.1440-1843.2005.00723.x</mixed-citation></ref><ref id="hanspub.27457-ref6"><label>6</label><mixed-citation publication-type="other" xlink:type="simple">Zandberg, D.P., Bhargava, R., Badin, S., et al. (2013) The Role of Human Papillomavirus in Nongenital Cancers. CA: A Cancer Journal for Clinicians, 63, 57-81. https://doi.org/10.3322/caac.21167</mixed-citation></ref><ref id="hanspub.27457-ref7"><label>7</label><mixed-citation publication-type="other" xlink:type="simple">Marur, S., D’Souza, G., Westra, W.H., et al. (2010) HPV-Associated Head and Neck Cancer: A Virus-Related Cancer Epidemic. Lancet Oncology, 11, 781-789. https://doi.org/10.1016/S1470-2045(10)70017-6</mixed-citation></ref><ref id="hanspub.27457-ref8"><label>8</label><mixed-citation publication-type="other" xlink:type="simple">Syrjanen, K.J. (1979) Condylomatous Changes in Neo-plastic Bronchial Epithelium. Report of a Case. Respration, 38, 299-304. https://doi.org/10.1159/000194095</mixed-citation></ref><ref id="hanspub.27457-ref9"><label>9</label><mixed-citation publication-type="other" xlink:type="simple">Klein, F., Amin, K.W. and Petersen, I. (2009) Incidence of Human Pap-illoma Virus in Lung Cancer. Lung Cancer, 65, 13-18. https://doi.org/10.1016/j.lungcan.2008.10.003</mixed-citation></ref><ref id="hanspub.27457-ref10"><label>10</label><mixed-citation publication-type="other" xlink:type="simple">Syr-janen, K.J. (2002) HPV Infections and Lung Cancer. Journal of Clinical Pathology, 55, 885-891.  
https://doi.org/10.1136/jcp.55.12.885</mixed-citation></ref><ref id="hanspub.27457-ref11"><label>11</label><mixed-citation publication-type="other" xlink:type="simple">Yano, T., Miura, N., Takenaka, T., et al. (2008) Never-Smoking Nonsmall Cell Lung Cancer as a Separate Entity: Clinicopathologic Features and Survival. Cancer, 113, 1012-1018. https://doi.org/10.1002/cncr.23679</mixed-citation></ref><ref id="hanspub.27457-ref12"><label>12</label><mixed-citation publication-type="other" xlink:type="simple">Cheng, Y.W., Chiou, H.L., Sheu, G.T., et al. (2001) The Association of Human Papillomavirus 16/18 Infection with Lung Cancer among Nonsmoking Taiwanese Women. Cancer Research, 61, 2799-2803.</mixed-citation></ref><ref id="hanspub.27457-ref13"><label>13</label><mixed-citation publication-type="other" xlink:type="simple">Matakidou, A., Eisen, T. and Houlston, R.S. (2005) Systematic Review of the Relationship between Family History and Lung Cancer Risk. British Journal of Cancer, 93, 825-833. https://doi.org/10.1038/sj.bjc.6602769</mixed-citation></ref><ref id="hanspub.27457-ref14"><label>14</label><mixed-citation publication-type="other" xlink:type="simple">Amabile, J.C., Leuraud, K., Vacquier, B., et al. (2009) Multifactorial Study of the Risk of Lung Cancer among French Uranium Miners: Radon, Smoking and Silicosis. Health Physics, 97, 613-621.  
https://doi.org/10.1097/01.HP.0000363842.62922.58</mixed-citation></ref><ref id="hanspub.27457-ref15"><label>15</label><mixed-citation publication-type="other" xlink:type="simple">Silverman, D.T., Lubin, J.H., Blair, A.E., et al. (2014) RE: The Diesel Exhaust in Miners Study (DEMS): A Nested Case-Control Study of Lung Cancer and Diesel Exhaust. Journal of the National Cancer Institute, 106.  
https://doi.org/10.1093/jnci/dju205</mixed-citation></ref><ref id="hanspub.27457-ref16"><label>16</label><mixed-citation publication-type="other" xlink:type="simple">Xue, X., Yin, Z., Lu, Y., et al. (2013) The Joint Effect of hOGG1, APE1, and ADPRT Polymorphisms and Cooking Oil Fumes on the Risk of Lung Adenocarcinoma in Chinese Non-Smoking Females. PLoS ONE, 8, e71157.  
https://doi.org/10.1371/journal.pone.0071157</mixed-citation></ref><ref id="hanspub.27457-ref17"><label>17</label><mixed-citation publication-type="other" xlink:type="simple">Narisawa-Saito, M. and Kiyono, T. (2007) Basic Mechanisms of High-Risk Human Papillomavirus-Induced Carcinogenesis: Roles of E6 and E7 Proteins. Cancer Science, 98, 1505-1511.  
https://doi.org/10.1111/j.1349-7006.2007.00546.x</mixed-citation></ref><ref id="hanspub.27457-ref18"><label>18</label><mixed-citation publication-type="other" xlink:type="simple">Clavel, C.E., Nawrocki, B., Bosseaux, B., et al. (2000) Detection of Human Papillomavirus DNA in Bronchopulmonary Carcinomas by Hybrid Capture II: A Study of 185 Tumors. Cancer, 88, 1347-1352.  
https://doi.org/10.1002/(SICI)1097-0142(20000315)88:6&lt;1347::AID-CNCR10&gt;3.0.CO;2-2</mixed-citation></ref><ref id="hanspub.27457-ref19"><label>19</label><mixed-citation publication-type="other" xlink:type="simple">Syrjanen, K.J. (1980) Epithelial Lesions Suggestive of a Condylomatous Origin Found Closely Associated with Invasive Bronchial Squamous Cell Carcinomas. Respiration, 40, 150-160. https://doi.org/10.1159/000194265</mixed-citation></ref><ref id="hanspub.27457-ref20"><label>20</label><mixed-citation publication-type="other" xlink:type="simple">Syrjanen, K.J. and Syrjanen, S.M. (1987) Human Papillomavirus DNA in Bronchial Squamous Cell Carcinomas. Lancet, 1, 168-169. https://doi.org/10.1016/S0140-6736(87)92010-1</mixed-citation></ref><ref id="hanspub.27457-ref21"><label>21</label><mixed-citation publication-type="other" xlink:type="simple">Pao, C.C., Hor, J.J., Yang, F.P., et al. (1997) Detection of Human Papillomavirus mRNA and Cervical Cancer Cells in Peripheral Blood of Cervical Cancer Patients with Metastasis. Journal of Clinical Oncology, 15, 1008-1012.  
https://doi.org/10.1200/JCO.1997.15.3.1008</mixed-citation></ref><ref id="hanspub.27457-ref22"><label>22</label><mixed-citation publication-type="other" xlink:type="simple">Coissard, C.J., Besson, G., Polette, M.C., et al. (2005) Preva-lence of Human Papillomaviruses in Lung Carcinomas: A Study of 218 Cases. Modern Pathology, 18, 1606-1609. https://doi.org/10.1038/modpathol.3800472</mixed-citation></ref><ref id="hanspub.27457-ref23"><label>23</label><mixed-citation publication-type="other" xlink:type="simple">Carpagnano, G.E., Koutelou, A., Natalicchio, M.I., et al. (2011) HPV in Exhaled Breath Condensate of Lung Cancer Patients. British Journal of Cancer, 105, 1183-1190. https://doi.org/10.1038/bjc.2011.354</mixed-citation></ref><ref id="hanspub.27457-ref24"><label>24</label><mixed-citation publication-type="other" xlink:type="simple">Cheng, Y.W., Wu, M.F., Wang, J., et al. (2007) Human Papillomavirus 16/18 E6 Oncoprotein Is Expressed in Lung Cancer and Related with p53 Inactivation. Cancer Research, 67, 10686-10693.  
https://doi.org/10.1158/0008-5472.CAN-07-1461</mixed-citation></ref><ref id="hanspub.27457-ref25"><label>25</label><mixed-citation publication-type="other" xlink:type="simple">Wu, D.W., Liu, W.S., Wang, J., et al. (2011) Reduced p21(WAF1/CIP1) via Alteration of p53-DDX3 Pathway Is Associated with Poor Relapse-Free Survival in Early-Stage Human Papillomavirus-Associated Lung Cancer. Clinical Cancer Research, 17, 1895-1905. https://doi.org/10.1158/1078-0432.CCR-10-2316</mixed-citation></ref><ref id="hanspub.27457-ref26"><label>26</label><mixed-citation publication-type="other" xlink:type="simple">Shih, C.M., Lee, Y.L., Chiou, H.L., et al. (2005) The In-volvement of Genetic Polymorphism of IL-10 Promoter in Non-Small Cell Lung Cancer. Lung Cancer, 50, 291-297. https://doi.org/10.1016/j.lungcan.2005.07.007</mixed-citation></ref><ref id="hanspub.27457-ref27"><label>27</label><mixed-citation publication-type="other" xlink:type="simple">Kato, T., Koriyama, C., Khan, N., et al. (2012) EGFR Muta-tions and Human Papillomavirus in Lung Cancer. Lung Cancer, 78, 144-147. https://doi.org/10.1016/j.lungcan.2012.08.011</mixed-citation></ref><ref id="hanspub.27457-ref28"><label>28</label><mixed-citation publication-type="other" xlink:type="simple">Wu, M.F., Cheng, Y.W., Lai, J.C., et al. (2005) Frequent p16INK4a Promoter Hypermethylation in Human Papillomavirus-Infected Female Lung Cancer in Taiwan. International Journal of Cancer, 113, 440-445.  
https://doi.org/10.1002/ijc.20597</mixed-citation></ref><ref id="hanspub.27457-ref29"><label>29</label><mixed-citation publication-type="other" xlink:type="simple">Sherr, C.J. and Mccormick, F. (2002) The RB and p53 Pathways in Cancer. Cancer Cell, 2, 103-112.  
https://doi.org/10.1016/S1535-6108(02)00102-2</mixed-citation></ref><ref id="hanspub.27457-ref30"><label>30</label><mixed-citation publication-type="other" xlink:type="simple">Finzer, P., Kuntzen, C., Soto, U., et al. (2001) Inhibitors of Histone Deacetylase Arrest Cell Cycle and Induce Apoptosis in Cervical Carcinoma Cells Circumventing Human Pap-illomavirus Oncogene Expression. Oncogene, 20, 4768-4776. https://doi.org/10.1038/sj.onc.1204652</mixed-citation></ref><ref id="hanspub.27457-ref31"><label>31</label><mixed-citation publication-type="other" xlink:type="simple">Ge, N.L. and Elferink, C.J. (1998) A Direct Interaction between the Aryl Hydrocarbon Receptor and Retinoblastoma protein. Linking Dioxin Signaling to the Cell Cycle. The Journal of Biological Chemistry, 273, 22708-22713.  
https://doi.org/10.1074/jbc.273.35.22708</mixed-citation></ref><ref id="hanspub.27457-ref32"><label>32</label><mixed-citation publication-type="other" xlink:type="simple">Whitlock, J.J. (1999) Induction of Cytochrome P4501A1. Annual Review of Pharmacology and Toxicology, 39, 103-125.  
https://doi.org/10.1146/annurev.pharmtox.39.1.103</mixed-citation></ref><ref id="hanspub.27457-ref33"><label>33</label><mixed-citation publication-type="other" xlink:type="simple">Elferink, C.J., Ge, N.L. and Levine, A. (2001) Maximal Aryl Hydrocarbon Receptor Activity Depends on an Interaction with the Retinoblastoma Protein. Molecular Pharma-cology, 59, 664-673. https://doi.org/10.1124/mol.59.4.664</mixed-citation></ref><ref id="hanspub.27457-ref34"><label>34</label><mixed-citation publication-type="other" xlink:type="simple">Burd, E.M. (2003) Human Papillomavirus and Cervical Cancer. Clinical Microbiology Reviews, 16, 1-17.  
https://doi.org/10.1128/CMR.16.1.1-17.2003</mixed-citation></ref><ref id="hanspub.27457-ref35"><label>35</label><mixed-citation publication-type="other" xlink:type="simple">Turek, L.P. and Smith, E.M. (1996) The Genetic Program of Genital Human Papillomaviruses in Infection and Cancer. Obstetrics and Gynecology Clinics of North America, 23, 735-758. https://doi.org/10.1016/S0889-8545(05)70275-8</mixed-citation></ref><ref id="hanspub.27457-ref36"><label>36</label><mixed-citation publication-type="other" xlink:type="simple">Pena, N., Carrillo, D., Munoz, J.P., et al. (2015) Tobacco Smoke Activates Human Papillomavirus 16 p97 Promoter and Cooperates with High-Risk E6/E7 for Oxidative DNA Damage in Lung Cells. PLoS ONE, 10, e123029.  
https://doi.org/10.1371/journal.pone.0123029</mixed-citation></ref></ref-list></back></article>